Jason Jung

Tracking US AI & Biotech alpha via institutional flow and insider positioning. Pure signal, zero noise. NFA.
👇AlphaSight (Insider buy&13F,D,G tracker)

[Jason Jung @Bioinsiderfact]

🚨 SMART MONEY IS BUYING THE DIP!

Fresh insider buys just filed (Alpha Sight data):

🔥 Standouts:
• $OPAD — CEO added \~$200K | Friday -16.5% 📉
• $AADX — Director + CFO added $660K | Friday -5.7%
• $ALDX — CEO added $418K | Friday -7.4%
• $HUBC — 10% owner added $594K | Friday -5.45%
• $SMMT — Co-CEO added $1.46M
• $TWFG — Director added \~$638K total
• $PRTA — 10% owner added $465K
• $BHRB — Director added $314K

Also loading up: $VTR (+$197K), $LTC, $NHI, $BBDC, $CRESY, $AVR, $VMAR, $DXST, $TOI & more.

Insiders buying aggressively into weakness = classic signal.

BUY THE DIP with the smart money before the crowd wakes up 💎

Track every insider trade, 13F & catalyst in real time:

👉 https://t.co/YqYCnfkTTI

#InsiderBuys #BuyTheDip #Stocks #AlphaSight

[Jason Jung @Bioinsiderfact]

Risks are real: execution on backlog, competition, macro sensitivity.
But the setup looks asymmetric from here — limited further downside vs. meaningful upside into earnings and beyond if the core thesis holds.
Not financial advice. DYOR. Position size accordingly on volatile names.
$BE #BloomEnergy #AIEnergy

[Jason Jung @Bioinsiderfact]

Bloom Energy just got slammed ~14% today on profit-taking and noise.
But this might be the last high-quality dip to buy before the next leg higher.
Here’s the case $BE

[Jason Jung @Bioinsiderfact]

This isn’t hopium.
It’s recognizing the difference between short-term headline noise (one gas deal + short-seller commentary) and multi-year structural demand for fast, reliable, on-site power that the grid can’t deliver quickly enough.
Smart money usually accumulates on days like today.

[Jason Jung @Bioinsiderfact]

Valuation has reset meaningfully after the vertical move.
From extremely stretched levels to something more reasonable right before a potential earnings catalyst.
High-beta names like this often shake out weak hands on exactly these days — then rip when the narrative reasserts.

[Jason Jung @Bioinsiderfact]

AI data center power demand is still accelerating.
US IT load is expected to roughly double by 2028.
Bloom isn’t fighting in theory — they’re converting real backlog while others are still debating timelines.
Q2 earnings (late July) should be the next real catalyst.

[Jason Jung @Bioinsiderfact]

The fundamentals haven’t changed:
Bloom sits on a ~$20B backlog from real hyperscalers who need power fast.
Their fuel cells deploy in 90-120 days.
Gas plants and nuclear take years.
One headline doesn’t erase multi-GW signed pipeline.

[Jason Jung @Bioinsiderfact]

What triggered the selloff:
• 1,300%+ run in 12 months → classic post-parabolic unwind
• One Chevron-Microsoft gas turbine deal for a Texas data center
• Jim Chanos calling the AI energy trade a bubble
• Barclays PT at $276 acting like a temporary ceiling
Nothing in the actual business broke. This is momentum mechanics.

[Jason Jung @Bioinsiderfact]

오늘자 (26년 6월22일)엔비디아 뉴스 🔥
$nvda
ISC 2026에서 차세대 컴퓨팅 플랫폼 ‘Vera Rubin’을 공개했는데, 내용이 진짜 압도적임.
-단일 랙에서 AI 기준 7엑사플롭스급 성능을 뽑아냄.
-Vera CPU + Rubin GPU 조합에 초고속 인터커넥트, 액체 냉각까지 풀스택으로 완성된 시스템이라서 기존과는 완전히 다른 수준
-이미 NERSC, LANL 같은 세계 최고 권위 국립연구소들이 선도입을 확정했고,
올해 4분기부터 바로 상용화에 들어간다는 소식
이제 엔비디아는 단순히 ‘GPU 잘 만드는 회사’가 아니라,고성능 컴퓨팅과 AI 인프라의 표준 자체를 정하는 위치에 올라섰음.
경쟁사들이 따라오기엔 해자(Moat)가 너무 두껍고 넓어진 것 같습니다.
이 흐름이 계속되면 AI 인프라 시장 지배력은 더 공고해질 전망입니다
#엔비디아 #Nvidia #VeraRubin #루빈GPU #AI인프라 #HPC #초고성능컴퓨팅 #테크트렌드 #주식 #AI투자

[Jason Jung @Bioinsiderfact]

🚨 Fresh Insider Buying Cluster
Multiple notable insider buys just dropped:
• $CAES — 10% Owner bought 600K shares ($6.00M) at $10.00
• $SAGT — CEO loaded up 1.5M shares ($1.56M) at $1.04
• $YYGH — 10% Owner accumulating heavily (nearly 2.5M shares across two buys)
• $PRTA — 10% Owner $158K buy
• $GOTU — CEO $143K buy
• $CAN — CEO $87.5K buy
Stocks seeing this kind of insider conviction have historically shown strong follow-through returns in the weeks and months after.
Smart money positioning early?
#InsiderTrading #Stocks

[Jason Jung @Bioinsiderfact]

Nvidia’s long-term trajectory remains one of the most debated stories in markets, blending extraordinary ecosystem strength with rising competitive and valuation risks. $NVDA
Beyond chip sales, Nvidia reportedly generated ~$15.9B in gains from equity stakes in AI companies it backed — a flywheel that reinforces its dominance as those firms scale with Nvidia hardware. Q1 FY2027 delivered another blowout: $81.6B revenue (+85% YoY) and $75.2B Data Center sales, with gross margins holding near 75%.
The bull case for $NVDA is clear. AI infrastructure spending shows no signs of slowing, and Nvidia’s full-stack moat (CUDA + networking + software) keeps it the default choice for most developers and enterprises. Many Wall Street analysts maintain bullish price targets well above current levels (some in the $300–350+ range), reflecting confidence that AI capex will continue driving multi-year growth.
However, risks are mounting. Hyperscalers are shifting more workloads to custom ASICs, with Broadcom’s AI revenue scaling aggressively and expected to take meaningful share among the largest spenders. Custom silicon could capture 35-40% of hyperscaler AI compute by 2028. While Nvidia’s software advantage remains formidable, this trend could gradually pressure its overall market share and growth rate.
Korea plays a quiet but vital role. SK Hynix and Samsung’s HBM supply (including HBM4 ramp) is a critical enabler for Nvidia’s roadmap, supported by multi-year agreements.
At current elevated valuations, $NVDA’s stock price outlook hinges on execution and AI spending sustainability. Strong continued growth could support further upside, but any meaningful slowdown in capex or faster-than-expected share loss to custom chips could trigger multiple compression.
Is the market underestimating Nvidia’s ability to defend its ecosystem, or is the current premium already pricing in near-perfect execution?

[Jason Jung @Bioinsiderfact]

$NVDA — AI infrastructure king
Consensus targets ~$300 (strong 40%+ upside from recent levels)
$AVGO — Custom AI chips + networking leader
Targets ~$510–522 (30%+ upside)
$MSFT — Azure + OpenAI + Copilot dominance
Consistent top-tier analyst favorite with solid upside
$META — AI capex + advertising machine
Bullish targets and strong growth outlook
$LLY — Weight-loss drugs + pipeline powerhouse
Major growth story with bullish Street targets
$MU — The AI memory (HBM/DRAM) play
Frequently called undervalued with big upside potential
$DELL — AI server infrastructure boom
High projected earnings growth (Zacks highlights)
$HPE — Strong momentum + earnings growth outlook
One of the highest growth projections in recent screens
$GOOGL — Search + YouTube + Cloud + AI bets
Core holding with steady analyst support
$SNOW — Data cloud platform
Fresh bullish notes and targets in the $300 range
These tickers combine momentum + real analyst conviction right now. AI infrastructure, data, and growth themes are leading the conversation.
Which ones are you watching or already in? Drop your top 3 below 👇
#Stocks #AIStocks #WallStreet #Investing #StockMarket

[Jason Jung @Bioinsiderfact]

🔥 SOFI CEO Anthony Noto just bought $250.8K!

+13,888 shares @ $18.06 | June 16, 2026

Despite recent net bearish insider flows ($2.16M sells vs $500K buys), the CEO stepped up and bought the dip.
Track every insider trade, 13F flow & catalyst in real-time with Alpha Sight.
👉 App Store & Google Play:
https://t.co/zlEehoLpnh
#SOFI #InsiderBuying #Stocks

[Jason Jung @Bioinsiderfact]

🚨 Fresh Insider Buys Just Hit the Tape! (June 15 Filings)
Smart money is loading up:
• $PBLS — RA Capital Management (Director)
→ 1.46M + 19.73M shares = $423.8M total at $20.00
• $LODE — Director Pei Steven Yu-Tsung
→ 250,000 shares combined (~$1.02M) at ~$4.10
• $ADSK — CFO Moorjani Janesh
→ 2,500 shares ($494.2K) at $197.67
• $MELI — SVP & Chief Accounting Officer
→ 12,464 shares ($200K) at $1,604.62
• $CTSO — CEO Chan Phillip P.
→ 251,136 shares ($100.5K) at just $0.40
• $FDP — Director Abu-Ghazaleh Ahmad
→ 4,000 shares ($117.6K)
• $ENPH — Director Trivedi Shanker
→ 1,000 shares ($53.9K)
Insiders voting with real capital. Coincidence… or signal? 👀
Track every move in real time on Alpha Sight.
Download now:
https://t.co/zlEehoLpnh
See what the smart money is doing — before the crowd 🔥
#InsiderBuys #SmartMoney #Stocks #AlphaSight

[Jason Jung @Bioinsiderfact]

🚨 Smart money is loading up RIGHT NOW
$SMMT — Co-CEOs just bought nearly $100M combined this month (one of the biggest insider signals this year)

Also seeing fresh buys in:
$HOOD (major director purchase)
$BLND (10% owner accumulating)
$QNT (Quantinuum — multiple directors buying post-IPO)
$WGS and a few others...

Stop digging through SEC filings manually.

Alpha Sight tracks every real-time Form 4, institutional flow, and catalyst so you catch these moves early.

Pro Membership = **1 WEEK FREE TRIAL** available now.

👉 Track the smart money here:
https://t.co/YqYCnfkTTI

#InsiderTrading #StockMarket #SmartMoney #SMMT #QNT

[Jason Jung @Bioinsiderfact]

🚨 SMART MONEY IS BUYING THE DIP!

Fresh insider buys just filed (Alpha Sight data):

🔥 Standouts:
• $OPAD — CEO added \~$200K | Friday -16.5% 📉
• $AADX — Director + CFO added $660K | Friday -5.7%
• $ALDX — CEO added $418K | Friday -7.4%
• $HUBC — 10% owner added $594K | Friday -5.45%
• $SMMT — Co-CEO added $1.46M
• $TWFG — Director added \~$638K total
• $PRTA — 10% owner added $465K
• $BHRB — Director added $314K

Also loading up: $VTR (+$197K), $LTC, $NHI, $BBDC, $CRESY, $AVR, $VMAR, $DXST, $TOI & more.

Insiders buying aggressively into weakness = classic signal.

BUY THE DIP with the smart money before the crowd wakes up 💎

Track every insider trade, 13F & catalyst in real time:

👉 https://t.co/YqYCnfkTTI

#InsiderBuys #BuyTheDip #Stocks #AlphaSight

[Jason Jung @Bioinsiderfact]

📈 $HOOD just showed exactly why insider buy signals matter.
6 days ago I highlighted it on X when it was trading at $82, backed by strong insider buying.
Today it’s at $96.
That’s a +17% move in under a week.
Smart money loading up isn’t just noise — it often leads the real moves.
This is the exact edge I built Alpha Sight to catch.
Want more setups like this before the crowd catches on?
👉 https://t.co/YqYCnfkTTI
See what the smart money is doing — before the crowd.
$HOOD #InsiderTrading #Stocks

[Jason Jung @Bioinsiderfact]

I’ll only say this once during this market dip:
The real strength to endure a bear market isn’t perfect timing — it’s holding stocks where insiders are buying with their own money.

Here are some tickers with notable insider buying signals I’ve highlighted recently:

$HCWB – Undervalued play with recent insider purchases (incl. CFO)
$INO – Biotech/vaccine innovator with smart money interest
$IONQ – Quantum computing leader
$SOFI – Fintech disruptor with recent CEO & insider buys
$HOOD – Fintech seeing positive Form

When the market shakes, these have stronger conviction behind them.
👇
https://t.co/zlEehoLpnh

[Jason Jung @Bioinsiderfact]

I’ll only say this once:

Smart money is already positioned in the names that actually matter right now.

$NVDA and $VST lighting up on explosive AI power demand.
$RKLB ripping higher ahead of Nasdaq-100 inclusion on June 22.
$LLY and $IONQ showing fresh institutional accumulation.

While retail chases headlines, the real signals are in the filings.

Alpha Sight turns every Form 4, 13F flow, and catalyst into clean, real-time cards — so you see what smart money is doing before the crowd.

Track it here 👇
https://t.co/lxFw1fwgLv

Which of these tickers are you watching closest right now? 👀

[Jason Jung @Bioinsiderfact]

@StockSavvyShay Congrats on the Nasdaq 100 inclusion! Space and AI infrastructure are two of the strongest long-term themes right now.
Tracking insider and institutional flows on names like these has been really useful: https://t.co/T54K52Dmqe 👀

[Jason Jung @Bioinsiderfact]

$SMMT insider buying is massive.
Both Co-CEOs bought nearly $50M each on June 12 at $13.12. That kind of aligned capital from insiders doesn’t happen often.
You can track these kinds of moves in real time at https://t.co/T54K52Dmqe 👀

[Jason Jung @Bioinsiderfact]

🔥 Social is buzzing hard with these right now (June 14).
Quick sector breakdown — AI infrastructure/memory momentum + biotech names with fresh smart money signals:
🚀 AI & Tech Infrastructure
$SNDK — Sandisk | AI storage/NAND boom | WS avg ~$1,580 (high $3,250)
$MU — Micron | AI HBM leader, earnings watch | WS avg ~$800 (high $1,750)
$NVDA — The AI king still driving every conversation
$PLTR — AI platforms + gov/commercial traction | WS avg ~$193 (high $255)
$NOW — Enterprise AI/software with recent exec buying signals
🧬 Biotech (Catalysts + Smart Money)
$SMMT — Summit Therapeutics | Strong pipeline flow | WS avg ~$27 (high $45)
(🚨 Massive insider buys June 12 — Co-CEOs each bought ~$50M at $13.12)
$LLY — Eli Lilly | Consistent top June pick, strong pipeline
$MRNA — Moderna | One of the stronger YTD biotech runners
$ABBV — AbbVie | Stability + growth name in broad “best stocks” lists
These are the ones getting real traction on X today.
Track real-time insider trades, institutional flows & catalysts before the crowd:
https://t.co/BpP0eBRFYp

[Jason Jung @Bioinsiderfact]

$HUBC Strategy Thoughts
Bullish case:
- Large player (HRT) stepping in with size right around split announcement
- App showing net bullish flow + upward short-term structure
- Post-split often brings volatility squeezes if accumulation continues

Risk case:
- Reverse splits frequently signal ongoing pressure
- HRT has been buying AND selling actively (not pure long conviction)
- Nasdaq compliance issues + weak fundamentals remain

My approach:
• Speculative long on dips if more buys appear in app
• Tight stops below key post-split levels
• Scale out into strength
• Use Alpha Sight to monitor real-time institutional flow

Who else is watching $HUBC post-split? Drop your levels 👇

[Jason Jung @Bioinsiderfact]

🚨 $HUBC Alpha Sight Catch 👀

HRT Financial LP (10% Owner) just made a major move:
✅ Big BUY flagged on Jun 3: +1.24M+ shares @ \~$0.53 (\~$660K)

Alpha Sight also tracking related sells around the same window — classic active trader behavior ahead of events.

1-for-20 reverse split announced (effective \~Jun 8). Stock extremely volatile as expected.

App metrics turning BULLISH:
• Buy flow 56% vs Sell 44%
• Short-term chart breaking higher

Smart money accumulating into the post-split reset?
High-risk/high-reward microcap cyber play.
Watch for follow-up filings + volume confirmation + upcoming earnings.

Screenshots from Alpha Sight below 👇
https://t.co/Ctn2bDAHPA
Not financial advice. DYOR. Penny stock = high risk of loss.